|Articles|May 13, 2015
Modeling Continuous Manufacturing Processes
Advertisement
Doug Hausner, associate director at the Engineering Research Center for Structured Organic Particulate Systems (CSOPS) at Rutgers, the State University of New Jersey, spoke with Pharmaceutical Technology at Interphex 2015 about how process modeling fits into the current state of continuous manufacturing of solid-dosage drug products and how modeling can be used to evaluate risk.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
Cellares Secures $257M to Scale Global Cell Therapy Manufacturing
3
Halo Pharma Becomes Dedicated North American Drug Product CDMO
4
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
5
